NANOG

NANOG is a transcription factor that is involved in the embryonic stem cell pluripotency and self-renewal. It is named after Tír na nÓg, a land of eternal youth in Irish mythology, reflecting the protein's role in promoting the immortal, undifferentiated state of stem cells. NANOG is a pivotal factor in the stem cell niche, particularly within the context of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs).

Function

NANOG operates within the nucleus of cells, where it plays a critical role in maintaining the pluripotency of stem cells. This means that it helps stem cells retain their ability to differentiate into any other cell type, a property known as pluripotency. It achieves this by promoting the expression of genes that keep the cell in an undifferentiated state while repressing genes that would lead to differentiation. NANOG works in concert with other transcription factors such as OCT4 and SOX2, forming a regulatory network that is essential for maintaining the unique properties of stem cells.

Gene

The NANOG gene is located on chromosome 12 in humans and contains multiple exons that can undergo alternative splicing, leading to different isoforms of the NANOG protein. The regulation of the NANOG gene is complex and involves various promoter and enhancer elements that respond to signaling pathways relevant to stem cell biology.

Clinical Significance

NANOG has been implicated in several clinical contexts, primarily due to its role in cell pluripotency and proliferation. Its expression is not only crucial for the generation and maintenance of stem cells but also has been observed in various cancer types. In cancers, high levels of NANOG expression are often associated with tumor aggressiveness, resistance to therapy, and poor prognosis. This is believed to be due to the protein's role in promoting cell proliferation and preventing cell differentiation, characteristics that are advantageous for tumor growth and survival.

Research and Applications

In the field of regenerative medicine, NANOG is a key target for research due to its potential in generating iPSCs from adult cells. This process, known as cellular reprogramming, holds promise for creating patient-specific cell therapies without the ethical and immunological issues associated with using embryonic stem cells. Additionally, understanding NANOG's role in cancer can lead to new therapeutic strategies that target the stem-like properties of cancer cells, potentially overcoming resistance to conventional therapies.

See Also

• Pluripotency
• Stem cell therapy
• Regenerative medicine
• Cancer stem cell

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian